Next Article in Journal
Role of the MicroRNAs in the Pathogenic Mechanism of Painful Symptoms in Long COVID: Systematic Review
Next Article in Special Issue
Comparative Evaluation of the Cytotoxic Effects of Metal Oxide and Metalloid Oxide Nanoparticles: An Experimental Study
Previous Article in Journal
Effects of 17α-Methyltestosterone on the Transcriptome and Sex Hormones in the Brain of Gobiocypris rarus
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Analysis of Experimental Data on Changes in Various Structures and Functions of the Rat Brain following Intranasal Administration of Fe2O3 Nanoparticles

by
Ilzira A. Minigalieva
1,2,*,
Yuliya V. Ryabova
1,2,
Ivan G. Shelomencev
1,
Lev A. Amromin
1,
Regina F. Minigalieva
1,2,
Yuliya M. Sutunkova
1,2,
Larisa I. Privalova
1,2 and
Marina P. Sutunkova
1
1
Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers, 30 Popov Street, 620014 Yekaterinburg, Russia
2
Laboratory of Stochastic Transport of Nanoparticles in Living Systems, Laboratory of Multi-Scale Mathematical Modeling, Ural Federal University, 51 Lenin Avenue, 620002 Yekaterinburg, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(4), 3572; https://doi.org/10.3390/ijms24043572
Submission received: 13 January 2023 / Revised: 31 January 2023 / Accepted: 6 February 2023 / Published: 10 February 2023
(This article belongs to the Special Issue Toxicology, Nanotoxicology and Occupational Diseases 2.0)

Abstract

:
Particulate matter, including iron nanoparticles, is one of the constituents of ambient air pollution. We assessed the effect of iron oxide (Fe2O3) nanoparticles on the structure and function of the brain of rats. Electron microscopy showed Fe2O3 nanoparticles in the tissues of olfactory bulbs but not in the basal ganglia of the brain after their subchronic intranasal administration. We observed an increase in the number of axons with damaged myelin sheaths and in the proportion of pathologically altered mitochondria in the brains of the exposed animals against the background of almost stable blood parameters. We conclude that the central nervous system can be a target for toxicity of low-dose exposure to Fe2O3 nanoparticles.

1. Introduction

The health effects of inhalation exposure to ultrafine particles in industrial workers have not been studied sufficiently so far. Numerous metallurgical processes and electric arc welding generate aerosols of iron condensation, containing submicron and nano-sized particles, the proportion of which can be as high as 40% of PM2.5 [1]. We assume that inhalation of such particles could be more detrimental to human health than expected based on mass measurements [2] in the absence of dispersion modeling.
Up-to-date literary sources describe multiple organ toxicity of iron oxide nanoparticles. The impact of iron-rich airborne particles on the cardiovascular system has been proven both in vivo using Danio rerio [3] and in epidemiological studies [4]. Adverse effects of iron oxide nanoparticles on the reproductive system, thyroid gland, and organs of the mononuclear phagocytic system are also known to date [5]. Toxicity of iron-rich nanoparticles has been shown in vitro for endothelial cells of the human umbilical vein of the HUVEC line [6], hepatomas of SK-Hep-1 and Hep3B lines [7], and neuroblastomas of the SHSY-5Y line [8], although the cytotoxic effect of these particles could not always be established unambiguously [9]. The ability of 2.3 and 4.2 nm Fe3O4 nanoparticles to induce oxidative stress, owing not only to the small size but also to their chemical identity, has been also demonstrated in vivo [10]. At the same time, physical parameters of iron oxide nanoparticles have a significant effect on cellular uptake, cytotoxicity, and their distribution and clearance [11].
Recent studies have proven that the central nervous system is one of the targets for toxicity of metal and metal oxide nanoparticles [12,13,14], which can penetrate into the brain by crossing the blood–brain barrier or by retrograde transport through the olfactory nerve endings [14,15,16,17].
The neurotoxic effect of iron nanoparticles, including those of Fe2O3, has been repeatedly evidenced by animal experiments. In their studies on mice exposed to Fe2O3 nanoparticles at doses of 25 and 50 mg/kg body weight for four weeks, Dhakshinamoorthy et al. showed a change in motor behavior and spatial memory, as well as impaired permeability of the blood–brain barrier and accumulation of nanoparticles in the brain. The authors associated the observed health effects with the accumulated nanoparticles, oxidative stress, and apoptosis in the brain of mice [18].
Maher B. et al. also associated the exposure to iron compounds (magnetite nanoparticles) with a unique combination of enhanced production of reactive oxygen species, surface charge, and strong magnetism [19].
Wu J. et al. [20] conducted a study with acute and subacute intranasal exposure of Sprague Dawley male rats to Fe2O3 nanoparticles and found the ability of the latter to deposit in brain tissues and damage the striatum [20]. Oral exposure to iron nanoparticles at a total dose of 5 mg/kg induced an increasing swelling of brain tissues observed histologically [21].
The kinetics of Fe2O3 was evaluated by Garcia-Fernandez J. et al. in in vitro studies by modeling the distribution of ultrasmall Fe2O3 particles in the gastrointestinal tract [22]. Popescu R. et al. showed that Fe3O4 could be captured by cells of tissue macrophages in the liver, spleen, and lungs [23,24]. Long-term studies conducted by Soares G et al. demonstrated poor clearance of nanoparticles and their increased accumulation in the liver and spleen [25]. In addition, nanoparticles of the same elemental composition but different sizes have unequal accumulation parameters [26]. At the same time, we have failed to find open access articles demonstrating the kinetics of iron oxide nanoparticles in brain structures.
The studies that we have found were conducted using relatively high doses of Fe2O3 nanoparticles. Current occupational exposure doses, however, demonstrate an obvious decreasing trend, e.g., in Canada [27], the United Kingdom [2], and the Russian Federation [28]. Data are accumulating on the dangers of low concentrations of nanoparticles (<1 μg/mL) in studies on Danio rerio [29]. Our objective was to establish whether Fe2O3 nanoparticles are capable of exerting toxic effects at low doses. Based on published data, we assumed that even low-dose exposure to iron oxide nanoparticles can induce changes at the ultrastructural and, probably, organismal level (behavioral reactions).

2. Results

2.1. Analysis of Experimental Data on General Toxic Effect

The analysis of the rats’ behavioral activity data revealed some statistically significant changes in different weeks of the exposure period (Figure 1). Total physical activity changed in the first place (Figure 1a): a pronounced downward trend was noted in each study group in weeks one to three, followed by a rise. However, while in the control group, locomotion recovered to the initial level and even exceeded it, that of the exposed animals demonstrated a pronounced decrease by the end of the experiment. In addition, while exploratory behavior, as judged by the number of head-dipping occurrences, in the control animals remained relatively stable, it dropped sharply in the exposed rats (Figure 1b).
Anxiety in the exposed animals was measured in the hole-board test by grooming (Figure 2a) and defecations (Figure 2b). According to the data obtained, the rats experienced some stress only in the third week of exposure, which leveled off by the end of the exposure period.
The reaction time of the rats to a stimulus differed significantly across the exposure period, as evidenced by changes in the summation threshold index shown in Figure 3. It is worth noting that statistical changes were observed already in week 1, which subsequently leveled off by the end of the experiment.
Due to the ambiguity of data on changes in behavioral reactions, we decided to analyze average indicators of behavior and summation threshold index, as shown in Table 1.
Despite the pronounced and unambiguous changes in the behavior of the exposed animals, we observed no significant changes in weight or hematological parameters. We can only note a statistically insignificant yet obvious increase in serum myelin basic protein (MBP) (2.99 ± 0.60 in the exposed animals against 2.44 ± 0.43 in the controls).
The analysis of the proportions of different cells in rhino-cytological wash specimens (Figure 4a) and imprint smears (Figure 4b) of the nasal cavity in both groups showed their comparability. Yet, the number of lymphocytes in eosinophils and macrophages demonstrated a slight rising trend.

2.2. Electron Microscopy Findings

Electron microscopy revealed deposits of Fe2O3 nanoparticles in tissues of olfactory bulbs of the rats’ brains; their composition was later confirmed by energy-dispersive X-ray spectroscopy (Figure 5a,b). Electron-dense objects containing Fe were not found in the samples from the control animals; no background signal was detected either.
Such an approach enables abstraction from the authors’ judgment about the objects observed and replaces them with objective EDS images when analyzing in high resolution. The method applied can only confirm the presence of nanoparticles in tissues but cannot prove their absence due to its low sensitivity.
We used electron microscopy to study the axons of the neurons in two parts of the rats’ brains for ultrastructural damage of myelin sheaths. The most common abnormality of the myelin sheath can be described as multiple-crater formations of different diameters and circumferences (Figure 6).
The examination of the ultrastructure of the myelin sheath showed an increase in the number of axons with the damaged myelin sheath in tissues of basal ganglia of 32.6% following the exposure to Fe2O3 NPs compared to the controls (Table 2).
We noticed a trend toward an increase in the proportion of axons with damaged myelin sheaths in the olfactory bulb; however, this pattern could not be statistically confirmed. There were also no significant differences in this indicator between brain regions within one group.
The mitochondrial profile was examined by electron microscopy according to the classification proposed by Sun et al. [30], based on the topology of the inner mitochondrial membrane: normal, normal vesicular, vesicular, swollen vesicular, and swollen. The analysis of electron microscopy images confirmed the presence of all five morphotypes of mitochondria in brain neurons in both groups of rodents (Figure 7).
Mitochondria were classified by two independent readers, and then, the distribution of mitochondrial morphotypes was assessed for each group of animals by brain regions (Figure 8).
Using Pearson’s goodness-of-fit test (χ2), we confirmed the abovementioned differences in the distribution of mitochondrial morphotypes between the exposed animals and the controls (χ2BG (4; 0.05) = 1090.6; p ≤ 0.0001; χ2OB (4; 0.05) = 1010.0; p ≤ 0.0001).
Detailing the alterations in the distribution of mitochondria by morphotypes by pairwise comparison of the Mann–Whitney U test reaffirmed that the proportion of mitochondria with the normal morphotype in tissues of basal ganglia of the exposed animals was 26.4% lower than that in the controls. The proportions of mitochondria of the normal vesicular and vesicular morphotypes were 31.9 and 10.0% higher in the exposed rats compared to the controls, respectively. In tissues of olfactory bulbs of the exposed animals, the proportions of mitochondria of the normal and swollen vesicular morphotypes were 36.4 and 4.9% lower than in the controls, respectively. The shares of mitochondria of the normal vesicular and vesicular morphotypes were 19.8 and 21.8% higher in the exposed rodents, respectively. In general, the distribution of mitochondria by morphotypes in the exposed animals was shifted toward the vesicular morphotype, with a predominance of the normal vesicular type compared to the controls.
We also established distinctions in the distribution of mitochondrial morphotypes between different brain regions in both groups (χ2control (4; 0.05) = 283.1; p ≤ 0.0001; χ2Fe2O3 NPs (4; 0.05) = 183.3; p ≤ 0.0001).
In the tissues of olfactory bulbs of the control animals, the proportion of mitochondria of the normal morphotype was 20.6% lower relative to the basal nuclei, and that of the normal vesicular one was 17.6% higher. In the rodents exposed to Fe2O3 NPs, we observed a similar trend toward a decrease in the proportion of normal mitochondria and an increase in that of mitochondria with damaged topology of the inner membrane in tissues of olfactory bulbs compared to basal nuclei. The percentage of mitochondria of the normal morphotype in tissues of olfactory bulbs was 14.7% lower; in contrast, the percentage of the vesicular morphotype was 12.1% higher.
However, no significant differences were found between mitochondria of the vesicular morphotype due to a high variability of values (p = 0.160; Mann–Whitney U test). The results of the paired Student’s t-test were similar for all the comparisons.

3. Discussion

We established the presence of nanoparticles in tissues of olfactory bulbs but not in basal ganglia. This finding is consistent with the theory of migration of nanoparticles to the brain along the olfactory nerve following inhalation exposure. This feature was noted for a number of metal nanoparticles [31,32]. Such a pattern of penetration of nanoparticles to brain tissues may be due to the advantage of the olfactory pathway where the blood–brain barrier is the most permeable [14,15]. Oberdörster et al. (in their study using, ca., 36-nm particles) concluded that the most likely mechanism of their penetration was deposition on the olfactory mucosa of the nasopharyngeal region of the respiratory tract and subsequent translocation through the olfactory nerve [33]. Maher et al. proved their conclusions in a large epidemiological study by establishing that magnetite nanoparticles could enter the brain directly through the olfactory nerve [19].
The absence of nanoparticles in basal ganglia can be a false negative due to the low sensitivity of the method in combination with a small number of Fe2O3 nanoparticles that have penetrated into basal ganglia. Fe2O3 might not be detected in basal ganglia due to changes in their physicochemical properties in the body, i.e., a possible formation of a protein corona [34] not assessed in our study. For instance, de Oliveira G et al. demonstrated a significant difference between the effects of dextran-coated IONPs (CLIO-NH2) and uncoated IONPs (UCIO) in zebrafish larvae [29].
It is worth noting that Fe2O3 NPs were found both in subcellular structures (e.g., cell nuclei and mitochondria) and in neuron cytoplasm. Our results are consistent with the findings of previous studies showing the presence of nanoparticles in intracellular structures, including mitochondria and nuclei, despite the differences in physical (shape and size) and chemical (silver and gold) characteristics of nanoparticles [35,36]. It is impossible to unambiguously conclude the mechanisms of penetration of Fe2O3 nanoparticles to subcellular structures, since the true mechanism of the toxic effect of nanoparticles may be the result of several risk factors acting simultaneously and difficult to differentiate (particle charge, shape, size, coating, chemical identity, and cellular uptake rate) [37].
Intranasal administration of Fe2O3 nanoparticles caused significant changes in behavior but not in cytological characteristics of nasal wash specimens and imprint smears of the nasal cavity, hematological parameters, or biochemical parameters of blood serum, with the exception of a statistically insignificant increase in the serum level of the myelin basic protein of 22.5%. Our findings are consistent with those reported by Badman et al. [38], proving that iron nanoparticles can be harmful to neurons at significantly lower concentrations than previously reported for other types of cells. We assume that we observed early signs of toxic effects at the organismal level [37]. The higher level of the myelin basic protein, the second most abundant protein in the myelin of the central nervous system [38] and a known marker of brain tissue damage [39], can give evidence of the damaged myelin sheath of axons. This damage was, in its turn, confirmed by electron microscopy results showing 1.6- and 1.4-fold increases in the number of axons with the damaged myelin sheath in tissues of basal ganglia (p < 0.05) and olfactory bulbs, respectively (Figure 5, Table 2). A decrease in the behavioral activity of the exposed animals, especially reduced locomotion, head dipping, and rearing (Figure 1 and Figure 2, Table 1), may indicate nerve conduction disorders in the central nervous system. Yet, the ability of the nervous system to sum up subthreshold impulses judged by the summation threshold index remained the same (Figure 2). Thus, damage to the myelin sheath related to exposure to Fe2O3 NPs in this case did not affect the nerve conduction velocity; we assume that either the damage was compensated for or our methods failed to detect “subtle” changes. Other components could potentially contribute to behavioral changes in the rats. Given the importance of mitochondrial function for neuronal health, interactions with nanoparticles can be detrimental to the nervous system. Mitochondrial damage could be immediately caused by the effect of Fe2O3 NPs on brain structures, which we assume following the detection of nanoparticles in them (Figure 4). The potency of such an effect has been previously demonstrated for silica [40], silver [41], and gold [42] nanoparticles. Induction of oxidative stress specific for most nanoparticles [43,44,45] could not be excluded either, since mitochondria are important targets for almost all types of damaging agents, including stress [46]. The damage to mitochondria could occur indirectly under the effect of dissolved iron in ionic form [46]. We cannot rule out the contribution of both nanoparticles and ferric ions to this damage.

4. Materials and Methods

4.1. Experimental Data

Within the framework of the present work, we have analyzed data obtained in a subchronic toxicity study of Fe2O3 nanoparticles (Fe2O3 NPs) sized 18 ± 4 nm in the total dose of 0.45 mg Fe2O3 NPs per rat, administered intranasally to three- to four-month-old female rats weighing about 200 g, with 12 animals per group. The choice of dose in the study we analyzed was limited by the nanoparticle concentration in the suspension and the maximum allowable volume for intranasal instillation in rats. The design of the experiment was similar to that described elsewhere [47]. The sample size was decided based on the experience acquired in our previous studies and the assumed minimum number of rodents necessary to obtain trustworthy results. Suspensions of Fe2O3 nanoparticles were prepared at the Ural Federal University, Yekaterinburg, Russian Federation, by pulsed-laser ablation of thin sheet targets of 99.9% pure iron in sterile deionized water, as described elsewhere [48]. We examined the results of the hole-board test used for assessing exploratory behaviors in rodents (head dips into holes and sniffing, locomotion, grooming, and defecations) and summation threshold index. To adjust for the bias caused by adaptation to stress related to injections, we averaged the hole-board test results and the summation threshold index for six weeks. We also examined the results of the rhino-cytological study of nasal wash specimens [49] and imprint smears of the nasal cavity [50] for seven animals. In addition, we considered the results of autopsies, general blood tests, biochemical tests (including the level of myelin basic protein), and electron microscopy images showing the severity of damage to both the myelin sheath of axons and mitochondria. Randomization of the visual fields and sample preparation for electron microscopy are shown in Figure 9.
Energy dispersive X-ray spectroscopy (EDS) spectra were analyzed using the AZtec software (Oxford Instruments, Abingdon, UK).
To identify Fe2O3 nanoparticles in rat brain structures, 420 ultrathin sections of two parts of the brain of the exposed and control animals were examined.
When analyzing morphological changes in the myelin sheaths of axons and assessing the state of neuron mitochondria, a series of five to six sections was prepared, and the highest quality ultrathin section of the series was divided into 20+ fields of view, evenly distributed over the entire surface, and then examined.
When determining the degree of damage to the myelin sheath of axons in sections of two regions of the brain, 1387 unique sites of the myelin sheath of axons (40 to 60 sites × 2 areas of the brain × 7 rats × 2 groups) were ranked by the presence or absence of damage to its structure.
When analyzing the damage to mitochondria following the exposure to nanoparticles, we assumed five successive stages of transformation of the inner membrane according to the classification of Sun et al. [30]. We ranked 4490 mitochondria in 84 samples from 14 rats of the control (n = 7) and experimental (n = 7) groups. Morphotyping was carried out by two independent readers to exclude bias in establishing mitochondrial morphotypes, after which the results of the percentage distribution of morphotypes were averaged for each type of tissue and animal.

4.2. Statistical Data Analysis

The statistical significance of data on behavioral reactions and blood parameters was established using the Student’s t-test. In addition, we compared p values estimated using the Student’s t-test and the Mann–Whitney U test, and their general coincidence proved the appropriateness of applying the t-test.
Scanning electron microscopy findings were analyzed using the Statistica 12 software. The statistical significance of differences in the distribution of mitochondrial profiles was assessed using Pearson’s goodness-of-fit test (χ2), while that between the groups was determined using the Mann–Whitney U test and Student’s t-test.
The difference between means was considered statistically significant if the probability of its occurrence by chance was equal to or less than 0.05 (p ≤ 0.05).

5. Conclusions

Our data analysis showed the ability of Fe2O3 nanoparticles at a total dose of 0.45 mg to have a toxic effect on rats. Administered intranasally, the particles significantly affected behavioral reactions but induced no changes in cytological characteristics of nasal swabs or imprint smears of the nasal cavity, hematological parameters, or biochemical indices of blood serum.
The examined kinetics demonstrated the ability of nanoparticles to enter the brain structures and to distribute unevenly in different parts of the rat’s brain. This conclusion requires further research to elucidate patterns of accumulation of Fe2O3 nanoparticles in the brain and to establish the dependence of their distribution therein on physical properties, dose, exposure duration, and route of administration of the nanoparticles. In addition, it is necessary to study correlations between the presence of nanoparticles in tissues, cells, and organelles, and ultrastructural damage to biological objects under study.

Author Contributions

Conceptualization, I.A.M., L.I.P., Y.V.R., and M.P.S.; methodology, R.F.M., Y.M.S., I.G.S., and L.A.A.; software, I.G.S. and L.A.A.; validation, I.A.M., L.I.P., and M.P.S.; formal analysis, R.F.M., Y.M.S., I.G.S., and L.A.A.; investigation, Y.V.R., I.G.S., and L.A.A.; data curation, I.A.M. and M.P.S.; writing—original draft preparation, Y.V.R. and L.A.A.; writing—review and editing, I.A.M., L.I.P., Y.V.R., and M.P.S.; visualization, Y.V.R., I.G.S., and L.A.A.; supervision, I.A.M. and M.P.S.; project administration, I.A.M. and M.P.S.; funding acquisition, I.A.M. and M.P.S. All authors have read and agreed to the published version of the manuscript.

Funding

The analysis was supported by the Ministry of Science and Higher Education of the Russian Federation within the “Priority—2030” Development Program of the Ural Federal University; the experimental data were provided by Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers.

Institutional Review Board Statement

The results of the experiment analyzed in the present article were approved by the local Ethics Committee of Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers, Minutes No. 2 of 20 April 2020.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Goddard, S.L.; Williams, K.R.; Robins, C.; Butterfield, D.M.; Brown, R.J.C. Concentration trends of metals in ambient air in the UK: A review. Environ. Monit. Assess. 2019, 191, 683. [Google Scholar] [CrossRef] [PubMed]
  2. Aitken, R.J.; Creely, K.S.; Tran, C.L. Nanoparticles: An Occupational Hygiene Review; Research Report 274; Institute of Occupational Medicine for the Health and Safety Executive: Edinburgh, UK, 2004; Available online: http://www.hse.gov.uk/research/rrpdf/rr274.pdf (accessed on 21 December 2022).
  3. Pereira, A.C.; Gonçalves, B.B.; Brito, R.S.; Vieira, L.G.; Lima, E.C.O.; Rocha, T.L. Comparative developmental toxicity of iron oxide nanoparticles and ferric chloride to zebrafish (Danio rerio) after static and semi-static exposure. Chemosphere 2020, 254, 126792. [Google Scholar] [CrossRef] [PubMed]
  4. Maher, B.A.; González-Maciel, A.; Reynoso-Robles, R.; Torres-Jardón, R.; Calderón-Garcidueñas, L. Iron-rich air pollution nanoparticles: An unrecognised environmental risk factor for myocardial mitochondrial dysfunction and cardiac oxidative stress. Environ. Res. 2020, 188, 109816. [Google Scholar] [CrossRef] [PubMed]
  5. Chrishtop, V.V.; Mironov, V.A.; Prilepskii, A.Y.; Nikonorova, V.G.; Vinogradov, V.V. Organ-specific toxicity of magnetic iron oxide-based nanoparticles. Nanotoxicology 2021, 15, 167–204. [Google Scholar] [CrossRef]
  6. Wu, X.; Tan, Y.; Mao, H.; Zhang, M. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int. J. Nanomed. 2010, 5, 385–399. [Google Scholar] [CrossRef]
  7. Xie, Y.; Liu, D.; Cai, C.; Chen, X.; Zhou, Y.; Wu, L.; Sun, Y.; Dai, H.; Kong, X.; Liu, P. Size-dependent cytotoxicity of Fe3O4 nanoparticles induced by biphasic regulation of oxidative stress in different human hepatoma cells. Int. J. Nanomed. 2016, 11, 3557–3570. [Google Scholar] [CrossRef]
  8. Imam, S.Z.; Lantz-McPeak, S.M.; Cuevas, E.; Rosas-Hernandez, H.; Liachenko, S.; Zhang, Y.; Sarkar, S.; Ramu, J.; Robinson, B.L.; Jones, Y.; et al. Iron oxide nanoparticles induce dopaminergic damage: In vitro pathways and in vivo imaging reveals mechanism of neuronal damage. Mol. Neurobiol. 2015, 52, 913–926. [Google Scholar] [CrossRef]
  9. Patil, R.M.; Thorat, N.D.; Shete, P.B.; Bedge, P.A.; Gavde, S.; Joshi, M.G.; Tofail, S.A.M.; Bohara, R.A. Comprehensive cytotoxicity studies of superparamagnetic iron oxide nanoparticles. Biochem. Biophys. Rep. 2018, 13, 63–72. [Google Scholar] [CrossRef] [PubMed]
  10. Wu, L.; Wen, W.; Wang, X.; Huang, D.; Cao, J.; Qi, X.; Shen, S. Ultrasmall iron oxide nanoparticles cause significant toxicity by specifically inducing acute oxidative stress to multiple organs. Part. Fibre Toxicol. 2022, 19, 24. [Google Scholar] [CrossRef]
  11. Feng, Q.; Liu, Y.; Huang, J.; Chen, K.; Huang, J.; Xiao, K. Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci. Rep. 2018, 8, 2082. [Google Scholar] [CrossRef] [Green Version]
  12. Khan, F.A.; Almohazey, D.; Alomari, M.; Almofty, S.A. Impact of nanoparticles on neuron biology: Current research trends. Int. J. Nanomed. 2018, 13, 2767–2776. [Google Scholar] [CrossRef] [PubMed]
  13. Karmakar, A.; Zhang, Q.; Zhang, Y. Neurotoxicity of nanoscale materials. J. Food Drug Anal. 2014, 22, 147–160. [Google Scholar] [CrossRef]
  14. Teleanu, D.M.; Chircov, C.; Grumezescu, A.M.; Teleanu, R.I. Neurotoxicity of nanomaterials: An up-to-date overview. Nanomaterials 2019, 9, 96. [Google Scholar] [CrossRef]
  15. Win-Shwe, T.T.; Fujimaki, H. Nanoparticles and neurotoxicity. Int. J. Mol. Sci. 2011, 12, 6267–6280. [Google Scholar] [CrossRef]
  16. Borisova, T. Nervous system injury in response to contact with environmental, engineered and planetary micro- and nano-sized particles. Front. Physiol. 2018, 9, 728. [Google Scholar] [CrossRef] [PubMed]
  17. Boyes, W.K.; van Thriel, C. Neurotoxicology of nanomaterials. Chem. Res. Toxicol. 2020, 33, 1121–1144. [Google Scholar] [CrossRef] [PubMed]
  18. Dhakshinamoorthy, V.; Manickam, V.; Perumal, E. Neurobehavioural toxicity of iron oxide nanoparticles in mice. Neurotox. Res. 2017, 32, 187–203. [Google Scholar] [CrossRef] [PubMed]
  19. Maher, B.A.; Ahmed, I.A.M.; Karloukovski, V.; MacLaren, D.A.; Foulds, P.G.; Allsop, D.; Mann, D.M.A.; Torres-Jardón, R.; Calderon-Garciduenas, L. Magnetite pollution nanoparticles in the human brain. Proc. Natl. Acad. Sci. USA 2016, 113, 10797–10801. [Google Scholar] [CrossRef]
  20. Wu, J.; Ding, T.; Sun, J. Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology 2013, 34, 243–253. [Google Scholar] [CrossRef]
  21. Navolokin, N.A.; Kun, S.M. Morphological changes of internal organs and brain at prolonged oral administration of iron nanoparticles. Saratov J. Med. Sci. Res. (Russ. J.) 2011, 7, 760–762. (In Russian) [Google Scholar]
  22. Garcia-Fernandez, J.; Turiel, D.; Bettmer, J.; Jakubowski, N.; Panne, U.; García, L.R.; Llopis, J.; Gonzáles, C.S.; Montes-Bayón, M. In vitro and in situ experiments to evaluate the biodistribution and cellular toxicity of ultrasmall iron oxide nanoparticles potentially used as oral iron supplements. Nanotoxicology 2020, 14, 388–403. [Google Scholar] [CrossRef] [PubMed]
  23. Popescu, R.C.; Vasile, B.S.; Savu, D.I.; Mogoşanu, G.D.; Bejenaru, L.E.; Andronescu, E.; Grumezescu, A.M.; Mogoantă, L. Influence of polymer shell molecular weight on functionalized iron oxide nanoparticles morphology and in vivo biodistribution. Pharmaceutics 2022, 14, 1877. [Google Scholar] [CrossRef] [PubMed]
  24. Zhang, J.; Ring, H.L.; Hurley, K.R.; Shao, Q.; Carlson, C.S.; Idiyatullin, D.; Manuchehrabadi, N.; Hoopes, P.J.; Haynes, C.L.; Bischof, J.C.; et al. Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T1 contrast for heating. Magn. Reson. Med. 2017, 78, 702–712. [Google Scholar] [CrossRef]
  25. Soares, G.A.; Faria, J.V.C.; Pinto, L.A.; Prospero, A.G.; Pereira, G.M.; Stoppa, E.G.; Buranello, L.P.; Bakuzis, A.F.; Baffa, O.; Miranda, J.R.A. Long-term clearance and biodistribution of magnetic nanoparticles assessed by AC biosusceptometry. Materials 2022, 15, 2121. [Google Scholar] [CrossRef] [PubMed]
  26. Pham, B.T.T.; Colvin, E.K.; Pham, N.T.H.; Kim, B.J.; Fuller, E.S.; Moon, E.A.; Barbey, R.; Yuen, S.; Rickman, B.H.; Bryce, N.S.; et al. Biodistribution and clearance of stable superparamagnetic maghemite iron oxide nanoparticles in mice following intraperitoneal administration. Int. J. Mol. Sci. 2018, 19, 205. [Google Scholar] [CrossRef]
  27. Environment and Climate Change Canada. Canadian Environmental Sustainability Indicators: Emissions of Harmful Substances to Air. Available online: https://www.canada.ca/en/environment-climate-change/services/environmental-indicators/emissions-harmful-substances-air.html (accessed on 7 December 2022).
  28. State Report on Sanitary and Epidemiological Well-Being of the Population in the Russian Federation in 2020. Available online: https://www.rospotrebnadzor.ru/upload/iblock/5fa/gd-seb_02.06-_s-podpisyu_pdf (accessed on 7 December 2022). (In Russian).
  29. de Oliveira, G.M.T.; de Oliveira, E.M.N.; Pereira, T.C.B.; Papaléo, R.M.; Bogo, M.R. Implications of exposure to dextran-coated and uncoated iron oxide nanoparticles to developmental toxicity in zebrafish. J. Nanopart. Res. 2017, 19, 389. [Google Scholar] [CrossRef]
  30. Sun, M.G.; Williams, J.; Munoz-Pinedo, C.; Perkins, G.A.; Brown, J.M.; Ellisman, M.H.; Green, D.R.; Frey, T.G. Correlated three-dimensional light and electron microscopy reveals transformation of mitochondria during apoptosis. Nat. Cell Biol. 2007, 9, 1057–1065. [Google Scholar] [CrossRef]
  31. Minigalieva, I.A.; Katsnelson, B.A.; Panov, V.G.; Privalova, L.I.; Varaksin, A.N.; Gurvich, V.B.; Sutunkova, M.P.; Shur, V.Y.; Shishkina, E.V.; Valamina, I.E.; et al. In vivo toxicity of copper oxide, lead oxide and zinc oxide nanoparticles acting in different combinations and its attenuation with a complex of innocuous bio-protectors. Toxicology 2017, 380, 72–93. [Google Scholar] [CrossRef]
  32. Dumková, J.; Smutná, T.; Vrlíková, L.; Le Coustumer, P.; Večeřa, Z.; Dočekal, B.; Mikuška, P.; Čapka, L.; Fictum, P.; Hampl, A.; et al. Sub-chronic inhalation of lead oxide nanoparticles revealed their broad distribution and tissue-specific subcellular localization in target organs. Part. Fibre Toxicol. 2017, 14, 55. [Google Scholar] [CrossRef] [PubMed]
  33. Oberdörster, G.; Sharp, Z.; Atudorei, V.; Elder, A.; Gelein, R.; Kreyling, W.; Cox, C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 2004, 16, 437–445. [Google Scholar] [CrossRef]
  34. Kopac, T. Protein corona, understanding the nanoparticle–protein interactions and future perspectives: A critical review. Int. J. Biol. Macromol. 2021, 169, 290–301. [Google Scholar] [CrossRef]
  35. Cramer, S.; Tacke, S.; Bornhorst, J.; Sachan, A.K.; Klingauf, J.; Schwerdtle, T.; Galla, H.-J. The influence of silver nano-particles on the blood-brain and the blood-cerebrospinal fluid barrier in vitro. J. Nanomed. Nanotechnol. 2014, 5, 1000225. [Google Scholar] [CrossRef]
  36. Panzarini, E.; Mariano, S.; Carata, E.; Mura, F.; Rossi, M.; Dini, L. Intracellular transport of silver and gold nanoparticles and biological responses: An update. Int. J. Mol. Sci. 2018, 19, 1305. [Google Scholar] [CrossRef]
  37. Badman, R.P.; Moore, S.L.; Killian, J.L.; Feng, T.; Cleland, T.A.; Hu, F.; Wang, M.D. Dextran-coated iron oxide nanoparticle-induced nanotoxicity in neuron cultures. Sci. Rep. 2020, 10, 11239. [Google Scholar] [CrossRef] [PubMed]
  38. Boggs, J.M. Myelin basic protein: A multifunctional protein. Cell Mol. Life Sci. 2006, 63, 1945–1961. [Google Scholar] [CrossRef] [PubMed]
  39. Wąsik, N.; Sokół, B.; Hołysz, M.; Mańko, W.; Juszkat, R.; Jagodziński, P.P.; Jankowski, R. Serum myelin basic protein as a marker of brain injury in aneurysmal subarachnoid haemorrhage. Acta Neurochir. (Wien) 2020, 162, 545–552. [Google Scholar] [CrossRef] [PubMed]
  40. Ducray, A.D.; Felser, A.; Zielinski, J.; Bittner, A.; Bürgi, J.V.; Nuoffer, J.M.; Frenz, M.; Mevissen, M. Effects of silica na-noparticle exposure on mitochondrial function during neuronal differentiation. J. Nanobiotechnol. 2017, 15, 49. [Google Scholar] [CrossRef]
  41. Strużyńska, L.; Skalska, J. Mechanisms underlying neurotoxicity of silver nanoparticles. Adv. Exp. Med. Biol. 2018, 1048, 227–250. [Google Scholar] [CrossRef]
  42. Tabatabaie, F.; Franich, R.; Feltis, B.; Geso, M. Oxidative damage to mitochondria enhanced by ionising radiation and gold nanoparticles in cancer cells. Int. J. Mol. Sci. 2022, 23, 6887. [Google Scholar] [CrossRef]
  43. Horie, M.; Tabei, Y. Role of oxidative stress in nanoparticles toxicity. Free Radic. Res. 2021, 55, 331–342. [Google Scholar] [CrossRef]
  44. Manke, A.; Wang, L.; Rojanasakul, Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. BioMed Res. Int. 2013, 2013, 942916. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Guo, C.; Sun, L.; Chen, X.; Zhang, D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen. Res. 2013, 21, 2003–2014. [Google Scholar] [CrossRef]
  46. Walter, P.B.; Knutson, M.D.; Paler-Martinez, A.; Lee, S.; Xu, Y.; Viteri, F.E.; Ames, B.N. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc. Natl. Acad. Sci. USA 2022, 99, 2264–2269. [Google Scholar] [CrossRef] [PubMed]
  47. Sutunkova, M.P.; Minigalieva, I.A.; Shelomencev, I.G.; Privalova, L.I.; Ryabova, Y.V.; Tazhigulova, A.V.; Amromin, L.A.; Minigalieva, R.F.; Sutunkova, Y.M.; Gurvich, V.B.; et al. Electron microscopy study on the transport of lead oxide nanoparticles into brain structures following their subchronic intranasal administration in rats. Sci. Rep. 2022, 12, 19444. [Google Scholar] [CrossRef] [PubMed]
  48. Privalova, L.I.; Katsnelson, B.A.; Loginova, N.V.; Gurvich, V.B.; Shur, V.Y.; Valamina, I.E.; Makeyev, O.H.; Sutunkova, M.P.; Minigalieva, I.A.; Kireyeva, E.P.; et al. Subchronic toxicity of copper oxide nanoparticles and its attenuation with the help of a combination of bioprotectors. Int. J. Mol. Sci. 2014, 15, 12379–12406. [Google Scholar] [CrossRef]
  49. Bogaerts, P.A.; Clement, P.A. Value of nose cytology as a diagnostic aid. Acta Otorhinolaryngol. Belg. 1981, 35, 67–73. (In Dutch) [Google Scholar]
  50. Sakhautdinova, R.R.; Sutunkova, M.P.; Minigalieva, I.A.; Bushueva, T.V. A cytological study of imprint smears (touch preparation cytology) to evaluate the toxicity of metal-containing nanoparticles in experimental animals. Hyg. Sanit. (Russ. J.) 2020, 99, 120–124. (In Russian) [Google Scholar] [CrossRef]
Figure 1. Results of the hole-board test: (a) general behavioral activity decreased by the end of week 6 in the exposed animals and increased in the controls; (b) number of head dips into holes sharply reduced by the end of the experiment in the exposed animals and was stable in the controls. The abscissa shows the exposure time in weeks, and the ordinate shows the value of the corresponding indicator; * compared with the controls; # compared with the value in the same group in week 1.
Figure 1. Results of the hole-board test: (a) general behavioral activity decreased by the end of week 6 in the exposed animals and increased in the controls; (b) number of head dips into holes sharply reduced by the end of the experiment in the exposed animals and was stable in the controls. The abscissa shows the exposure time in weeks, and the ordinate shows the value of the corresponding indicator; * compared with the controls; # compared with the value in the same group in week 1.
Ijms 24 03572 g001
Figure 2. Hole-board test results: (a) grooming; (b) defecations. Based on the graphs, the rats experienced some stress in week 3 of intranasal injections of Fe2O3 or deionized water, while the level of anxiety of exposed animals in week 4 and until the end of the experiment was lower than that of animals in the control group. The abscissa shows the exposure time in weeks and the ordinate shows the value of the corresponding indicator; * compared with the controls; # compared with the value in the same group in week 1.
Figure 2. Hole-board test results: (a) grooming; (b) defecations. Based on the graphs, the rats experienced some stress in week 3 of intranasal injections of Fe2O3 or deionized water, while the level of anxiety of exposed animals in week 4 and until the end of the experiment was lower than that of animals in the control group. The abscissa shows the exposure time in weeks and the ordinate shows the value of the corresponding indicator; * compared with the controls; # compared with the value in the same group in week 1.
Ijms 24 03572 g002
Figure 3. Changes in the summation threshold index. The reaction time of the rats to a stimulus differed significantly across the exposure period. The abscissa shows the exposure time in weeks, and the ordinate shows the value of the corresponding indicator; * compared with the controls; # compared with the value in the same group in week 1.
Figure 3. Changes in the summation threshold index. The reaction time of the rats to a stimulus differed significantly across the exposure period. The abscissa shows the exposure time in weeks, and the ordinate shows the value of the corresponding indicator; * compared with the controls; # compared with the value in the same group in week 1.
Ijms 24 03572 g003
Figure 4. Proportion of cells of different types in rhino-cytological wash specimens (a) and imprint smears (b) of the nasal cavity in the exposed and control rodents.
Figure 4. Proportion of cells of different types in rhino-cytological wash specimens (a) and imprint smears (b) of the nasal cavity in the exposed and control rodents.
Ijms 24 03572 g004
Figure 5. (a,b) STEM images of the olfactory bulb tissues with deposits of Fe2O3 nanoparticles and (c) without them in the control rodents; (df) EDS spectra of the regions marked on image (a), (b) and (c), respectively.
Figure 5. (a,b) STEM images of the olfactory bulb tissues with deposits of Fe2O3 nanoparticles and (c) without them in the control rodents; (df) EDS spectra of the regions marked on image (a), (b) and (c), respectively.
Ijms 24 03572 g005
Figure 6. Representative STEM images of the normal (A) and damaged (B) myelin sheath.
Figure 6. Representative STEM images of the normal (A) and damaged (B) myelin sheath.
Ijms 24 03572 g006
Figure 7. Representative STEM images of normal (A), normal vesicular (B), vesicular (C), swollen vesicular (D), and swollen (E) mitochondrial morphotypes found in animal tissues in both groups of rats.
Figure 7. Representative STEM images of normal (A), normal vesicular (B), vesicular (C), swollen vesicular (D), and swollen (E) mitochondrial morphotypes found in animal tissues in both groups of rats.
Ijms 24 03572 g007
Figure 8. Damage to the ultrastructure of neuronal mitochondria in the animals exposed to Fe2O3 nanoparticles and controls by brain regions: (a) basal ganglia and (b) olfactory bulb. Notes: values are given as the arithmetic mean of the percentage of mitochondria in the total number of detected neuronal mitochondria; * p < 0.05 (Mann–Whitney U test) compared with the controls.
Figure 8. Damage to the ultrastructure of neuronal mitochondria in the animals exposed to Fe2O3 nanoparticles and controls by brain regions: (a) basal ganglia and (b) olfactory bulb. Notes: values are given as the arithmetic mean of the percentage of mitochondria in the total number of detected neuronal mitochondria; * p < 0.05 (Mann–Whitney U test) compared with the controls.
Ijms 24 03572 g008
Figure 9. Sampling and sample preparation for electron microscopy.
Figure 9. Sampling and sample preparation for electron microscopy.
Ijms 24 03572 g009
Table 1. Average indicators of behavioral reactions of rats in the hole-board test.
Table 1. Average indicators of behavioral reactions of rats in the hole-board test.
VariablesControl Group
(Deionized Water)
Exposure Group
(Fe2O3 NPs)
Summation threshold index11.63 ± 0.4310.93 ± 0.34
Total activity (except defecations)38.58 ± 2.3418.70 ± 1.62 *
Head lifting6.94 ± 0.93 3.60 ± 0.66 *
Rearing0.86 ± 0.150.21 ± 0.06 *
Locomotion12.54 ± 0.88 6.00 ± 0.52 *
Head dipping8.83 ± 0.604.83 ± 0.38 *
Hole sniffing8.74 ± 0.773.26 ± 0.52 *
Grooming (5 s—1 score)0.68 ± 0.090.80 ± 0.18
Defecations0.60 ± 0.120.77 ± 0.14
* p ≤ 0.05 (Student’s t-test), compared with the control group.
Table 2. Damage to the ultrastructure of myelin sheaths of axons in two parts of the brain in the rats exposed to Fe2O3 nanoparticles and the control animals.
Table 2. Damage to the ultrastructure of myelin sheaths of axons in two parts of the brain in the rats exposed to Fe2O3 nanoparticles and the control animals.
Part of BrainDamaged Areas of the Myelin Sheath (Mean ± 95% CI), %
Control GroupExposure Group
Olfactory bulb57.0 ± 9.481.6 ± 21.5
Basal ganglia50.9 ± 8.183.5 ± 9.7 *
Values are given as the proportion of axons with damaged sheaths of the total number of axons detected; * p < 0.05 (Mann–Whitney U test) compared with the controls.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Minigalieva, I.A.; Ryabova, Y.V.; Shelomencev, I.G.; Amromin, L.A.; Minigalieva, R.F.; Sutunkova, Y.M.; Privalova, L.I.; Sutunkova, M.P. Analysis of Experimental Data on Changes in Various Structures and Functions of the Rat Brain following Intranasal Administration of Fe2O3 Nanoparticles. Int. J. Mol. Sci. 2023, 24, 3572. https://doi.org/10.3390/ijms24043572

AMA Style

Minigalieva IA, Ryabova YV, Shelomencev IG, Amromin LA, Minigalieva RF, Sutunkova YM, Privalova LI, Sutunkova MP. Analysis of Experimental Data on Changes in Various Structures and Functions of the Rat Brain following Intranasal Administration of Fe2O3 Nanoparticles. International Journal of Molecular Sciences. 2023; 24(4):3572. https://doi.org/10.3390/ijms24043572

Chicago/Turabian Style

Minigalieva, Ilzira A., Yuliya V. Ryabova, Ivan G. Shelomencev, Lev A. Amromin, Regina F. Minigalieva, Yuliya M. Sutunkova, Larisa I. Privalova, and Marina P. Sutunkova. 2023. "Analysis of Experimental Data on Changes in Various Structures and Functions of the Rat Brain following Intranasal Administration of Fe2O3 Nanoparticles" International Journal of Molecular Sciences 24, no. 4: 3572. https://doi.org/10.3390/ijms24043572

APA Style

Minigalieva, I. A., Ryabova, Y. V., Shelomencev, I. G., Amromin, L. A., Minigalieva, R. F., Sutunkova, Y. M., Privalova, L. I., & Sutunkova, M. P. (2023). Analysis of Experimental Data on Changes in Various Structures and Functions of the Rat Brain following Intranasal Administration of Fe2O3 Nanoparticles. International Journal of Molecular Sciences, 24(4), 3572. https://doi.org/10.3390/ijms24043572

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop